MEDSECUREAN.COM for INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Aug 12, 2024 | — | Replaced |
| 2nd Quarter - Report (this page) | Aug 12, 2024 | — | Replaced |
| 2nd Quarter - Amendment | Mar 5, 2025 | $15,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Derisking the Affordable Medicine Supply Chain (KSMs, APIs), seeking a US-India trade partnership that can be expanded to other trusted allies. Partnership concept includes industry sustainability, quality metrics, market demand, domestic and allied manufacturing, suite of financial tools among others. During this quarter, only engaged in outreach to set up meetings for a CEO delegation Fly-In for Late April.
Foreign entity interest: Indian Pharmaceutical Association is a trade association in India, representing key innovative and affordable medicine manufacturers. These manufacturers supply nearly 50% of Medicare Prescriptions, and of the top 10 US therapeutic categories, the companies supply more than half of the prescriptions for 5 of the top 10 categories-ranging up to 60%.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN JAEGER New | — |
Trade (domestic/foreign) TRD
Derisking the Affordable Medicine Supply Chain (KSMs, APIs), seeking a US-India trade partnership that can be expanded to other trusted allies. Partnership concept includes industry sustainability, quality metrics, market demand, domestic and allied manufacturing, suite of financial tools among others. During this quarter, only engaged in outreach to set up meetings for a CEO delegation Fly-In for Late April.
Foreign entity interest: Indian Pharmaceutical Asociation is a trade association in India, representing innovative and affordable medicine manufacturers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN JAEGER New | — |
Defense DEF
Derisking the Affordable Medicine Supply Chain (KSMs, APIs), seeking a US-India trade partnership that can be expanded to other trusted allies. Partnership concept includes industry sustainability, quality metrics, market demand, domestic and allied manufacturing, suite of financial tools among others. During this quarter, only engaged in outreach to set up meetings for a CEO delegation Fly-In for Late April.
Foreign entity interest: Indian Pharmaceutical Association is a trade association in India, representing innovative and affordable medicine manufacturers who supply nearly half of the affordable medicine used in the U.S.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN JAEGER New | — |
Homeland Security HOM
Derisking the Affordable Medicine Supply Chain (KSMs, APIs), seeking a US-India trade partnership that can be expanded to other trusted allies. Partnership concept includes industry sustainability, quality metrics, market demand, domestic and allied manufacturing, suite of financial tools among others. During this quarter, only engaged in outreach to set up meetings for a CEO delegation Fly-In for Late April.
Foreign entity interest: Indian Pharmaceutical Association is a trade association in India, representing innovative and affordable medicine manufacturers who supply the U.S. with nearly 50% of affordable medicine used in the U.S.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN JAEGER New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.